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Abstract 
 
Many cancer patients are diagnosed through emergency presentations, which are associated with poorer 
clinical and patient-reported outcomes. Reducing the proportion of cancer patients who are diagnosed as 
emergencies is desirable, but the optimal means for achieving this aim are uncertain as tumour, patient 
and healthcare factors are involved, often in combination. We reviewed the literature to inform future 
policy and research. Most evidence relates to few high-income countries, colorectal and lung cancer, and 
defines emergency presentations contextually (e.g. whether patients presented to emergency health care 
services and/or received emergency treatment shortly before their diagnosis). Consistent variations in risk 
of emergency presentations by patient characteristic and cancer type have been described, but there is 
limited evidence on whether and how such presentations can be prevented. Evidence about symptoms 
and healthcare utilisation prior to emergency presentations is sparse. 
 
Interventions aimed at improving earlier diagnosis of cancer will also reduce emergency presentations. 
These may include: 
• Optimising uptake of screening interventions (e.g. colorectal cancer); 
• Addressing access or psychosocial barriers to prompt help-seeking for symptoms; 
• Enabling point-of-care testing and access to rapid specialist / multi-disciplinary diagnostic 
assessment and tests. 
 
Additionally, reconfiguring out-of-hours cover by oncology services to optimise the treatment of 
emergency presenters may improve their outcomes. 
 
Harmonising definitions and data collection methods can help in surveillance and international 
comparisons. Research on emergency presentations in low/middle income countries, child and young adult 
patients, and those with rarer cancers should be prioritised. 
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Introduction 
 
Most cancer patients are diagnosed after symptom onset, and many present to emergency care services, 
often with life-threatening manifestations of their underlying cancer. (1-5) The diagnosis of cancer as an 
emergency is associated with poorer clinical and patient-reported outcomes. These include less frequent 
use of treatment with curative intent, well established associations between emergency presentations, 
and poorer survival and worse quality of life and patient experience. 
 
Specifically evidence for patients with many common and rarer solid tumours, including colorectal, 
oesophageal and lung cancer, indicates that emergency presenters are less likely to be treated with 
curative intent (denoted in 3 out of the 4 studies in available literature with use of respective surgery).(6-9) 
The association between emergency presentation and less frequent use of treatments with curative intent 
persists after adjustment for socio-demographic and tumour factors including, critically, stage at 
diagnosis.(8, 9) 
 
Further, emergency presentation is associated with lower 1-year survival for patients with any of 15 
cancers compared with electively diagnosed cases (e.g. 50% vs 82% for colorectal and 12% vs 40% for lung 
cancer).(5) Associations between emergency presentation and poorer survival are particularly strong in the 
short-term (e.g. 1-month and 1-year as opposed to 5-year).(6, 8, 10-12) Although stage at diagnosis explains 
part of this association, emergency presentations are independently associated with lower survival even 
after adjustment for stage.(13, 14) 
 
Lastly, considering patient-generated outcomes, evidence from a national patient experience report 
indicates that emergency presenters report worse experience of subsequent cancer care (15). 
 
Consequently, decreasing the proportion of cancer patients who are diagnosed through emergency 
presentations is desirable. However, complex mechanisms leading to such events, involving tumour, 
patient and healthcare factors, make progress towards this objective challenging.(16) 
 
Motivated by these considerations, we provide a critical overview of the current evidence about the 
complex problem of diagnosis of cancer as an emergency. Our objective is to better inform future public 
health and healthcare interventions and research aimed at reducing the proportion of cancer patients who 
are diagnosed as emergencies. 
 
After examining relevant conceptual and operational definitions, we consider theoretical frameworks 
about how emergency diagnoses of cancer could be prevented. We review evidence on prior healthcare 
utilisation and symptoms among emergency presenters; and the frequency and predictors of emergency 
presentations, specifically focusing on how socio-demographic inequalities vary for patients with different 
cancers. Lastly we describe priorities for future policy initiatives and research. We base our analysis on a 
recent systematic review of the evidence (Box 1), additionally drawing on our prior clinical, public health 
and research experience. 
 
[INSERT BOX 1] 
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1. Evidence overview 
 
Study Selection 
A reviewer (YZ) performed the search and subsequently screened the titles, and where appropriate the 
abstracts, of 13,972 yielded publications. A second reviewer (GL) independently screened 10% of the initial 
yield of titles and abstracts. Disagreements between the two raters were discussed and adjudicated. Both 
reviewers subsequently independently assessed the full texts of 26 studies initially judged as relevant, of 
which 4 were subsequently excluded (3 were conference abstracts and 1 was not population-based). Two 
studies had a great degree of overlap in the presented data, and the earlier and less comprehensive paper 
was excluded.(17) References in relevant articles were hand-searched for additional articles meeting 
inclusion criteria, leading to the inclusion of 2 additional studies. An additional study and relevant grey 
literature were added based on prior knowledge of the authors, resulting in the final inclusion of 24 peer-
reviewed publications (Appendix 1) and 6 online reports. 
 
The peer-reviewed publications relate to patient populations from 6 countries, namely England (17), 
Scotland (1), USA (2), Sweden (2), Canada (1), and France (1). Online reports relate to evidence from 
England, including reports based on the Routes to Diagnosis project, a clinical audit report, and a multi-
center European study on emergency presentation of lung cancer.(7, 18-22) In total, evidence relates to 35 
cancer sites in peer-reviewed papers, and a few additional (rarer) cancer sites are also covered by online 
reports.(23, 24) However, most of the evidence relates to only two cancers: colorectal – commonly treated as 
a single site, and lung cancer. Most of the evidence (e.g. 16/24 publications and most online reports) has 
been published since 2012, indicating a growing interest in this field. 
 
2. Data sources and definitions 
 
Data sources: Most evidence arises from large administrative or electronic patient record datasets (e.g. 
‘Routes to Diagnosis’ data in England, or SEER-Medicare data in the United States). In fewer studies data 
were collected through direct inspection of patient records by clinicians or trained researchers. (25-28) A 
third category includes publications arising from clinical audit initiatives (a quality improvement activity 
based on the inspection of medical records). (2, 6, 8, 10) 
 
Definitions: There is a substantial degree of heterogeneity in how the diagnosis of cancer as an emergency 
is defined in different studies. In general, operational definitions employ either contextual criteria [i.e. 
whether the patient’s cancer diagnosis followed a presentation to emergency healthcare services (e.g. 
Accidents and Emergency department)] and/or clinical information criteria [i.e. whether urgent (surgical) 
treatment was used, or whether certain symptoms were present] (Figure 1). Studies using clinical 
information criteria relate to colorectal cancer only. In two studies emergency diagnosis status was defined 
based on information generated by clinical staff.(10, 29) Definitional and methodological differences are 
likely to account for different point estimates of the frequency of emergency presentations reported 
previously. (30) 
 
[INSERT FIGURE 1] 
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3. Can emergency presentations be prevented? 
 
We found no empirical evidence directly assessing whether emergency presentations were preventable, 
with three exceptions: First, a clinical audit initiative in England, which judged the potential for preventing 
emergency presentations by exploring whether emergency presenters had previously consulted with ‘red 
flag’ symptoms mandating urgent referral for suspected cancer. They found that 23% of emergency 
presenters did in retrospect meet the referral criteria.(20) Second, a qualitative analysis of a small case-
series of English emergency presenters, described potential breakdowns in the diagnostic process, and the 
need for better communication of diagnostic uncertainty to encourage symptom re-appraisal and help-
seeking.(31) The third relates to a qualitative synthesis of a large series of significant event analysis in 
England, which showed that the complexity of tumour/ biological factors may deem some emergency 
presentations unavoidable. However, it has also been suggested that some patient factors and health 
system initiatives may reduce a proportion of avoidable cases. (32) All these three sources relate to clinical 
audit initiatives to reduce emergency presentations; it is likely that a much greater number of such local 
initiatives have examined preventability but most such evidence remains unpublished.(33) The dearth of 
published evidence on the potential to prevent emergency presentations in cancer patients is striking, 
considered against the mature literature on judging the preventability of general emergency hospital 
admissions (or emergency department use) or readmissions.(34, 35) 
 
These findings indicate the need for studies examining the potential for avoiding emergency presentations 
in the future. Here we propose a framework on which future research can be based, incorporating the 
influence of tumour (disease), patient and healthcare factors, (16) and a diagnostic timeliness dimension 
incorporating aspects of the “Pathways to Treatment” model by Walter et al (Figure 2). (36) In Figure 2 and 
subsequent text, the term “potentially avoidable” refers to the emergency presentation event, while the 
modifiable factors relate to the predictors such events. 
 
[INSERT FIGURE 2] 
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4. Trends, frequency and variation in EP by tumour factors 
 
Time trends 
 
Evidence based on the Routes to Diagnosis dataset suggests substantial reductions in the overall frequency 
of EP for all cancers over time in England.(1, 5, 37) Specifically, a reduction from 24% to 20% was noted for 
patients with any cancer between 2006 and 2013. (19) Reductions were greater for malignancies associated 
with high baseline proportion of emergency diagnosis, such as lung cancer (from 39% in 2006 to 34% in 
2013). (19) In contrast, no discernible changes were observed for ‘easy-to-suspect’ cancers which are 
associated with very low baseline (<5%) proportion of emergency presenters (such as breast cancer and 
melanoma).(19) 
 
When regarding trends over time in the proportions of cancer patients diagnosed as an emergency, it is 
useful to consider the factors to which notable/strong trends in short periods of time can be attributed to 
– in general, temporal changes in short period of time are unlikely to reflect changes in disease factors 
(such as tumour aggressiveness) as tumour morphology is unlikely to rapidly change. Therefore it can be 
hypothesised that if such changes are observed, they are more likely to reflect changes in patient and 
healthcare factors. 
 
 
Tumour factors 
 
Cancer site (and sub-site/sub-type) 
Most evidence relates to 4 only cancers, i.e. colorectal, lung, breast cancer, and upper GI (oesophago-
gastric) cancers (Appendix 2). 
 
Overall, reported frequencies of emergency diagnosis varied significantly across different cancer types, 
from 2% for melanoma to more than 60% for brain and central nervous system tumours.(5, 24, 37) 
Frequencies >30% are reported for patients with brain and central nervous system, cancer of unknown 
primary, pancreatic, lung, stomach, acute leukaemia and multiple myeloma. At the other end of the 
spectrum, melanoma, breast, oropharyngeal, oral, uterine, testicular and prostate cancer present as 
emergencies in < 10% of all cases. 
 
As remarked previously, these findings suggest a correlation between the ‘symptom signature’ (or 
diagnostic difficulty) of different cancers and reported proportions of patients diagnosed as 
emergencies.(38) Cancers where most patients present with visible or palpable symptoms/signs (e.g. 
melanoma and breast cancer) have typically low proportions of emergency presenters, whereas the 
opposite is true for cancers where most patients present with non-specific symptoms (e.g. pancreatic 
cancer or multiple myeloma). It is however also important to consider the role of minimal prior symptoms 
in some cancers (e.g. seizure as first symptom of brain cancer) and primary care test utilisation for others 
(e.g. acute lymphocytic leukaemia, often diagnosed after a full blood count investigation). 
 
Beyond general variation by major organ site, variation in tumour sub-site or subtype is also described for 
a small number of cancers (colorectal, colon, oesophago-gastric cancer and leukaemias) (Box 2). 
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Grade/Histology 
Only one American study considered the effect of cancer grade and histology on the likelihood of 
emergency presentations.(3) A higher proportion of high grade (poorly 
differentiated/undifferentiated/anaplastic) colorectal cancers were found to present as an emergency than 
low (well/moderately differentiated) grade colorectal cancers (32% vs 28%). Mucinous adenocarcinoma or 
signet ring cell tumours were more likely to present as an emergency than ‘other adenocarcinoma’ (31% vs 
28%). 
 
Tumour or host biomarkers 
We found no relevant evidence about tumour or host biomarkers predisposing to emergency presentation. 
Such associations however are highly likely, in spite of lack of evidence currently. For example, within a 
given organ (e.g. ovary or pancreas), certain types of tumours may be associated with higher or lower risk 
of emergency presentation. 
 
[INSERT BOX 2]
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5. Healthcare utilisation and presenting symptoms among prior consultees 
 
Consistent with our prior theoretical framing, judging the potential for preventing emergency 
presentations requires consideration of whether patients had presented previously, and if so with what 
symptoms. 
 
5a. Prior healthcare utilisation 
 
Prior primary care utilisation 
 
Seven studies (five from UK, and one each from Sweden and the US) studying patients with ovarian, lung, 
and colorectal cancer documented that most (between two thirds and four-fifths) of emergency presenters 
have had prior primary care consultation. (4, 11, 25-28, 40) 
 
Evidence from a national English data source indicates that about 30% of emergency presentations are 
generated by direct emergency referral to hospital services by primary care physicians. (23) Concordantly, 
evidence from three small primary care studies indicates that up to 20% of cancer patients who have 
consulted their general practitioner are referred as an emergency.(25-27) Whether this patient group has 
also had prior ‘elective’ primary care presentations (before the contact with primary care leading to the 
emergency) is unclear. 
 
In some patients an investigation plan and/or referral has been made but an emergency presentation 
occurs in the interval between referral and planned investigation or specialist assessment. Other than one 
study (26), evidence on this patient group is poorly described in the current literature. A quarter of the 39 
emergency presenters in the Barrett et al study had an emergency admission while waiting for a specialist 
appointment. (26) These patients may benefit from shortening of intervals to investigations or assessment. 
(41) 
 
Despite relatively high proportion of patients with prior consultations (80%) among emergency presenters, 
when compared to cancers diagnosed electively, they are less likely to have consulted in primary care prior 
to diagnosis.(4, 11, 40) This indirectly suggests that among patients subsequently diagnosed with cancer, prior 
consultations may well lower the risk of diagnosis as an emergency, supporting the need for improving 
access and reducing barriers to help-seeking where those are present. (42) 
 
Prior secondary care utilisation 
 
After excluding periods of 1-2 months before diagnosis (to avoid accounting for hospital care directly 
relating to the emergency presentation itself), three studies on colorectal cancer patients (two from US 
and one from UK) reported higher rates of prior inpatient and emergency admissions in emergency 
presenters compared with electively-diagnosed cancer patients. (3, 4, 40) 
 
These findings may indicate that cancer patients who are diagnosed as emergencies may have higher levels 
of co-morbidity unrelated to their cancer; or suggest that emergency presenters are clustered within a 
patient group with higher than average use of Accident and Emergency department as opposed to primary 
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care services either due to personal choice (43) or primary care access barriers, including insurance status in 
the US health system. (3, 4) 
 
Investigations prior to emergency presentation 
 
Three studies on colorectal cancer reported that patients who had investigations prior to their colorectal 
cancer diagnosis were less likely to present as emergencies.(3, 11, 39) For example, Gunnarsson et al. 
reported lower prior colonoscopy and other investigations use in emergency presenters compared with 
electively diagnosed cancer patients (i.e. 10% vs 63% of emergency vs non-emergency presenters had a 
prior colonoscopy, while the respective figures for abdominal imaging studies were 15% vs 61%). Whether 
these prior investigations were performed for screening or the evaluation of symptoms was not reported 
in any of these three studies. These findings nonetheless indicate that prior endoscopic or imaging 
investigations may minimise the risk of diagnosis of cancer as an emergency. 
 
5b. Preceding symptomatic presentations 
 
Identifying symptoms associated with higher risk of subsequent diagnosis of cancer as an emergency can 
help to identify patient groups in which emergency presentations may potentially be averted. Thus far, 
evidence on prior symptoms relates to patients who consulted previously – i.e. it excludes a substantial 
group of patients who have not consulted before their emergency diagnosis (see above). 
 
To avoid potential conflation of prior potential cancer symptoms with those directly triggering the 
emergency presentation event, optimally, prior symptom data should exclude the period of time directly 
preceding the emergency presentation (e.g. up to a month prior). However only one of the three studies 
with relevant data consistently applied such a design feature.(28) 
 
Current empirical evidence about associations between prior symptoms and emergency diagnosis chiefly 
relates to patients diagnosed with colorectal cancer. Colorectal cancer patients diagnosed through 
emergency presentations are more likely to have previously seen their doctor with abdominal pain (11, 28, 
40), change of bowel habit (particularly constipation (11, 28, 40)) and weight loss (11, 28). They are less likely to 
have consulted for rectal bleeding (11, 28, 40) and anaemia. (11) 
 
Although limited to colorectal cancer patients, some evidence suggests that patients who present with 
symptoms of lower predictive value for cancer are more likely to be diagnosed as emergencies. (11, 28, 40) 
While reducing the referral threshold for suspected cancer may reduce emergency presentations, this will 
also result in higher proportions of patients without cancer being also referred. Evidence on prior 
symptoms, clearly differentiating prior symptoms from those prompting the emergency presentation 
event, is needed for colon and rectal cancers separately, as well as for other malignancies. 
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6. Healthcare system factors 
 
Most cancer patients initially present to non-specialists. Examining primary care organisation (such as 
through qualitative studies involving significant event analysis or quantitative studies examining practice-
level characteristics and emergency presentation) and the impact of screening services can shed light on 
potentially remediable factors that contribute to emergency diagnoses. The available evidence mainly 
relates to studies examining associations between general practice characteristics (activity or 
performance) and emergency diagnosis. 
 
General practice characteristics 
Two English studies reported the association between practice characteristics and emergency 
presentations. Poorer in-hours primary care access (as measured by patients’ ability to get an appointment 
within two days) (odds ratio 0.85 CI 0.79 – 0.92, p<0.0001 for patients in practices in the highest vs lowest 
quartiles of Quality and Outcomes Framework (clinical quality) points) (1) was found to independently 
predict the risk of emergency presentation (all cancer site). In the same paper, higher than average 
proportion of non-UK qualified practice doctors, and smaller practice list size were associated with higher 
odds of emergency presentation in the practice population. No association was found between continuity 
and emergency presentation in another primary care study – which however is likely to have under-
estimated the true frequency of emergency presentations due to the unrepresentative sample of cases 
that have been included in this study. (44) 
 
Access to primary care was examined by 2 North-American studies – both in the context of colorectal 
cancer. In a Canadian study, having a regular source of primary care was associated with a lower risk of 
diagnosis of colorectal cancer as an emergency (odds ratio 0.70 CI 0.65 – 0.77, no p-value “yes” vs “no” to 
regular source) (39). Using a data item included in the US Medicare-SEER dataset, Pruitt et al. examined 
associations with ‘prior preventable hospitalisations’, as a proxy measure for access to primary care 
services. Patients with preventable hospitalisations a year before diagnosis were more likely to be 
diagnosed with cancer as emergencies than those without (e.g. emergency diagnosis rates of 50% vs 27% 
in colorectal cancer patients with and without preventable hospitalisation respectively). (3) 
 
Primary care performance characteristics 
In an English ecological study that reported performance characteristics, practices with a lower rate of 
upper-gastrointestinal endoscopy were associated with a higher emergency presentation risk of gastro-
oesophageal cancers. (45) 
 
Impact of screening 
For cancers with effective screening programmes, no study has examined direct (individual level) 
associations between screening uptake history and risk of emergency presentation during follow-up 
periods. However, ecological ‘before and after’ studies indicate that colorectal cancer screening 
interventions can decrease the proportion of colorectal cancer patients who are diagnosed as 
emergencies, (24, 46-48) especially in the screening age group of 60-69 year olds (21% in 2006 to 16% in 
2012). (24) For example, introduction of Faecal Occult Blood Test (FOBT) screening in a UK region was 
associated with a 47% decrease in the proportions of colorectal cancer patients in the same 
geographically-defined population who were diagnosed as emergencies between 1999 and 2004.(46) Similar 
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trends were observed in Scotland between 2003 and 2012 (i.e. pre- / post-FOBT screening introduction) 
with a reported reduction in the absolute proportion of patients diagnosed through emergency 
presentations from 20% to 13%.(48) Although these ecological studies suggest positive impact of screening 
on population rates of EP, possibly through the detection of symptomatic cases at an earlier stage, (47, 49) 
other interventions promoting earlier diagnosis (for example, cancer awareness campaigns) may have also 
contribute to the observed patterns. No relevant evidence exists for any other cancer (e.g. breast, cervical, 
lung). It should be noted that the impact of screening programmes on risk of emergency presentation may 
vary for different countries and healthcare systems, as the nature of screening programmes, and resultant 
population coverage and programme effectiveness is variable, and influenced by a range of organisational 
and social factors which are also likely to differ. It has been suggested that racial/ethnic disparities in 
colorectal cancer screening may explain in major part differences in emergency presentation in the US 
setting, (3) but the likely impact of inequalities in screening as a source of inequalities in emergency 
presentation in other countries could vary. 
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7. Stage at diagnosis 
 
Stage at diagnosis reflects tumour biology (i.e. the intrinsic malignant potential of the tumour at 
oncogenesis) and at the same time it is also a function of tumour growth over time (and, consequently, a 
function of time to diagnosis). 
 
Several studies have consistently reported that cancer patients who are diagnosed as emergencies are 
more likely to have advanced stage cancers (Box 3). In a recent report published on the routes to diagnosis 
by stage for 10 cancer sites in England, 30% of EP patients have stage 4 cancers at diagnosis, compared to 
17% and 14% of those diagnosed through a fast-track (“2-week-wait”) and non-urgent (non-2-week-wait) 
referral respectively. (21) The same source indicates that proportion of emergency presenters diagnosed at 
stage 4 varies notably between the different (10) studied cancers, from 18% and 20% for melanoma and 
prostate, to 44% and 45% for lung and ovarian cancer respectively. 
 
[INSERT BOX 3] 
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8. Patient factors 
 
8a. Sociodemographic inequalities in the frequency of emergency diagnosis of cancer, and interactions 
between patient characteristics and cancers 
 
In part socio-demographic associations with risk of emergency presentations may reflect disease factors 
(e.g. age differences in tumour sub-types, or anatomical differences between the two sexes). However, 
some of these differences may reflect socio-cultural influences on patient help-seeking behaviour, or 
healthcare inequalities. How overall socio-demographic inequalities vary for different cancers may be 
particularly revealing of the potential to reduce emergency presentations. 
 
Age 
Cancer patients at the either extremes of age (the youngest and the very old patients) are more likely to be 
diagnosed as emergencies. 
 
Adults: In general older age is associated with higher risk of emergency diagnosis, with the risk in patients 
above the age of 80 being particularly pronounced.(1-6, 8, 10, 11, 14, 29, 39, 40, 44, 45, 50) For example, English 
patients above age 85 and over are 2.5 times as likely as those age 65 – 74 to present as an emergency (for 
all non-gender specific cancers), (37); similarly, for colorectal cancer patients age 90 are at 3 times greater 
risk compared to those age 70 (2). 
 
Interactions between age and cancer: When considering age as a ‘main effect’, variation in this 
relationship between different cancers can be masked. Specifically, some cancers exhibit a more 
positive association between increasing (adult) age and risk of emergency diagnosis, while for 
others there is a more complex J- or U-shaped pattern. For acute lymphocytic leukaemia there is a 
negative association (increasing age being associated with lower risk of emergency 
presentation).(37) Interactions between cancer and age are likely to reflect disease factors. 
 
Children and young adults: The majority of studies excluded patients below the age of 25, with the 
exception of two relevant studies in the peer-reviewed evidence and two items of grey literature (5, 14, 18, 24). 
More than half (54%) of patients aged 0-14 are diagnosed as emergencies (5). For most of the cancer 
groups examined, patients aged 0-14 years in England were more likely to be diagnosed as an emergency 
than those aged 15-24 years;  leukaemias and central nervous system (CNS) tumours were most likely to 
be diagnosed as an emergency, with 69% and 57% of 0-14 year olds with leukaemias and CNS tumours 
respectively being diagnosed as an emergency. (18) 
 
 
Socioeconomic status 
There is substantial evidence for an association between measures of lower socioeconomic status and 
greater risk of diagnosis of cancer as an emergency, as also recently reported by a systematic review 
specifically focused on lung and colorectal cancer. (1-4, 10, 14, 29, 37, 39, 44, 45, 50, 51) Different studies have defined 
socioeconomic status either using direct measures (e.g. individual income or insurance status), or 
ecologically (based on the socioeconomic characteristics of a small area population where an individual 
resides). Given the increasing use of ecological measures, we use the terms deprivation and socioeconomic 
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status interchangeably hereafter in the paper. In the US, deprivation and being insured by MedicAid (an 
insurance program for socioeconomically deprived patients) have also been implicated in their associations 
with increased EP for lung and colorectal cancer.(3, 4) 
 
Interactions between socioeconomic status and cancer: Although evidence for a cancer-
deprivation relationship is present for most non-gender specific cancers, there is at present only 
one study which examined cancer-specific associations between socioeconomic status and EP 
across a range of different (27) cancers. A positive association (greater risk of emergency 
presentation among the most deprived patients) was particularly strong for patients with oral, 
oropharyngeal, and anal cancers – possibly indicating socioeconomic patterning of normalisation of 
relatively indolent initial symptoms (oral/oropharyngeal cancer) or stigma associated with reporting 
of symptoms in sensitive areas (anal cancer).(37) 
 
Sex 
Overall variation in risk of emergency presentation by sex is relatively small and largely a reflection of 
variable cancer site case-mix (37). While women have been found to be at increased risk of EP in some 
studies,(1, 2, 4, 6, 8, 39, 45, 50) few other studies found no association between sex and risk of emergency 
diagnosis.(10, 29, 40) 
 
Interactions between sex and cancer; and sex and socioeconomic status: The risk of emergency 
presentation is notably higher for women with bladder cancer compared to men with bladder 
cancer, most likely reflecting difficulties of suspecting the diagnosis of bladder cancer in women.(37, 
52) There are also interactions between sex and socioeconomic status, with Swedish men of the 
lowest income quartile being more likely than lowest income women to be diagnosed with 
colorectal cancer as an emergency.(29) 
 
Ethnicity 
Non-white patients (2) and those of Asian background (1) in the UK, as well as African-Americans in the US (3, 
4) have been found to be more likely to present as an emergency (Box 4). For example, in a large-scale 
American study on colorectal cancer conducted by Pruitt, African Americans were 28% more likely than 
White Americans to have an emergency diagnosis and emergency surgery for colorectal cancer (3). 
 
[INSERT BOX 4] 
 
8b. Pre-diagnosis comorbidity and performance status 
 
Co-morbid illness has been consistently reported to be a risk factor for EP. Patients with increasing 
comorbidities (especially 3 or more) are more likely to be diagnosed with cancer in an emergency setting (2-
4, 8, 14, 44, 45). Patients with dementia and those with cerebrovascular disease are 2.5 and 1.7 times as likely 
to present as emergencies than those without these comorbid conditions (e.g. odds ratio 2.46 CI 2.18 – 
2.79 for dementia).(2). On the other hand, no independent associations between comorbidity and 
emergency presentation risk were reported for chronic respiratory disease, diabetes and cardiovascular 
disease.(2, 11) Two studies using data from clinical audit initiatives found that poorer performance status 
was associated with higher risk of emergency diagnosis.(8, 10) 
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8c. Psychosocial factors 
 
A Swedish study examined the potential role of marriage, as a marker of social isolation: it found that 
unmarried patients with colorectal cancer were more likely to be diagnosed as emergencies than their 
married counterparts (odds ratio 1.24, 95% CI 1.04 – 1.49 unmarried vs married patients), after adjustment 
for other confounders.(29) Other psychosocial factors which have been found to be associated with 
screening uptake and help-seeking behaviour include fear of cancer or fatalism, (53) and measures of 
cognitive (awareness), emotional or attitudinal barriers, (42, 54, 55) but no associations with emergency 
presentation were reported in the reviewed evidence. 
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Discussion 
 
We considered evidence on the definitions, frequency and potential for preventing emergency 
presentation of cancers taking into account available evidence to the end of 2015. It is notable that current 
evidence relates only to 6 developed countries, and overwhelmingly relates to UK patient populations and 
the English Routes-to-Diagnosis project (Box 5). However, given the consistency of the evidence within 
studies from these 6 countries, it is highly unlikely that emergency presentation is anything but a global 
challenge, as also recently highlighted by a study in European hospitals.(22) Studying emergency 
presentations in other international populations should be addressed by future research. 
 
[INSERT BOX 5] 
 
In most of the evidence emergency presentations are most commonly defined contextually, for example as 
diagnosis of cancer shortly after presentation to an emergency department or an emergency admission. 
For colorectal cancer patients only, at times contextual definitions are supplemented with information on 
clinical symptoms or emergency surgery. Only a minority of studies bases the definition of emergency 
presentation on the evaluation of clinical records. Nonetheless, use of administrative data analysis offers 
great advantages in terms of identification of inequalities and should be further explored and refined. 
 
Associations between emergency presentations and a range of both potentially modifiable (e.g. prior 
consultations) and non-modifiable (e.g. tumour grade) factors have been described. However, quantifying 
the exact aetiological contribution of modifiable and non-modifiable influences remains poorly described 
in current literature. Recently a notable downward trend in the proportion of emergency presentations has 
been reported in England. (24) This strongly indicates that modifiable patient and healthcare factors do play 
a role, and possibly reflects the impact of public health campaigns (such as ‘Be Clear on Cancer’ in England) 
and healthcare interventions aiming to improve cancer diagnosis (such as the introduction of clinical 
guidelines for fast track assessment of patients at higher risk of cancer). (56, 57);  
Early diagnosis interventions will be effective in reducing emergency presentations of cancer. For example, 
screening interventions (particularly for colorectal cancer) can help to prevent emergency presentations. 
Consequently efforts to increase uptake in the general population and decrease inequalities are needed. 
The development of effective screening tests for a number of cancers for which no such tests exist 
currently can lead to reductions in emergency presentations. However, such initiatives may also result in 
harm, such as over-diagnosis and over-treatment following screening. While reducing referral or 
investigation thresholds may reduce emergency presentations, it will also result in higher proportions of 
patients without cancer being also referred. Detailed description of these issues is outside the scope of this 
review. 
  
A substantial minority of emergency presenters have no prior contact with the formal healthcare system. 
This may indicate the influence of biopsychosocial factors such as normalization of symptoms and not 
appreciating the seriousness of symptoms, particularly in the presence of co-morbid conditions and older 
age. (42, 55, 58, 59) Other contextual and cultural factors moderating the way in which people recognise, 
interpret and act on their symptoms include the influence of family and friends, fatalism, (53, 60) and fear of 
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cancer diagnosis and its treatment. (61) Access to appropriate use of healthcare services and concerns about 
wasting doctors’ time could also act as barriers to help-seeking for these patients. (62) This growing 
evidence base indicates the need for ongoing development of public health education campaigns about 
cancer. 
 
Nonetheless, the majority of patients have seen a general practitioner previously, while some have had 
contact with secondary care services (including emergency services). (31) Interventions that shorten 
diagnostic intervals and support / streamline the diagnostic process should therefore help reduce the 
proportion of emergency presentations. 
 
Patients who present as an emergency are less likely to receive treatment with curative intent; and have 
worse (particularly short-term) survival. Both these associations are partly explained by stage at diagnosis 
but are maintained as independent associations even after adjustment. Therefore, although these 
observations may reflect unmeasured tumour aggressiveness, they may also indicate suboptimal 
diagnostic work-up and treatment in emergency presenters. Improvements in outcomes may therefore be 
possible by re-configuring how out-of-hours emergencies are covered by specialist medical and surgical 
oncology services. (11) 
 
It has been previously argued that: “Interventions should aim to reduce the proportion of patients with 
cancer who are diagnosed as emergencies to the absolute minimum dictated by tumor aggressiveness, 
having removed the potential influence of either healthcare or patient factors”. (16) Concordantly and give 
our review, we propose and advocate the following recommendations for informing clinical practice, public 
health policy and research.  
 
RECOMMENDATIONS BOX 
 
1. Defining and measuring emergency diagnoses  
 
a. Definitions: Studies should explicitly describe whether they define emergency presentations  
contextually (i.e. if emergency care services were used) and/or clinically (i.e. if criteria about potentially life 
threatening symptoms and/or requirement for emergency treatment are met). * 
 
b. Studies using algorithmic definitions in electronic health records should: i) aim to incorporate validation 
components based on direct inspection of random sub-samples of patient records *; ii) describe algorithms 
adequately to enable comparisons between countries/healthcare systems with different data infrastructures 
and diagnostic pathways. * 
 
c. Studies using patient records reviews (20, 31, 32) can be optimally supported by data collection instruments 
which: i) explicitly consider the potential influence of contributing tumour (disease, biological), patient and 
healthcare (provider or organisational) factors; ii) allow judgements about the potential preventability of 
emergency presentations.  
 
2. Preventing emergency presentations in patients without prior relevant healthcare utilisation 
 
a. Given that some emergency presenters have no prior relevant consultations, (4, 11, 20, 25-27, 32, 39, 40, 44) 
evidence is needed to help better understand the characteristics of these patients and their possible 
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preceding symptoms, together with potential access (including insurance coverage) or psychosocial 
barriers to help-seeking in this patient group.  
 
 
3. Preventing emergency presentations in patients with prior relevant consultations / healthcare 
utilisation 
  
More evidence is needed on the prior consultations / healthcare utilisation patterns in these patients to 
identify higher risk groups. It is important that symptoms suggestive of cancer at an earlier stage and acute 
symptoms triggering the emergency presentation event itself are distinguished in such studies. (28) 
 
4. Optimising organisational / healthcare system factors 
 
a. Supporting the diagnostic process by reducing thresholds for specialist referral and enabling access to 
investigations could help prevent some emergency presentations. * 
 
b. New models of diagnostic services (such as multidisciplinary one stop diagnostic clinics) for patients with 
atypical / ‘vague’ symptoms should help reduce emergency presentations, (63) given that some emergency 
presentations occur while patients are awaiting or undergoing elective investigation. (25-28, 31, 32)  
 
c. As screening for colorectal cancer may reduce emergency presentations, (46-48) policy initiatives and 
research are needed to increase its population uptake and decrease related inequalities. Future 
development of effective screening programmes (e.g. for lung cancer) could further reduce emergency 
presentations *.   
d. Initiatives to increase use of early detection interventions for symptomatic patients or in the context 
screening should encompass the evaluation of potential harms from over-diagnosis and cost-effectiveness, 
which are increasingly being considered in clinical practice and research studies. (64)  
 
 
5. Improving outcomes in emergency presenters 
 
a. Research is needed to understand the associations between emergency presentation and lower use of 
curative treatments, and the reasons why emergency presenters have poorer survival compared with 
electively diagnosed patients of the same stage. (10, 14, 21) 
 
b. Reconfiguration of out-of-hours coverage of emergencies by specialist oncology service may help to 
improve clinical outcomes in patients diagnosed through an emergency presentation. (11) 
 
 
6. Emergency diagnosis of cancer as a likely global challenge  
 
a. Given that evidence is currently restricted to patient populations from only 6 countries, researchers and 
policy makers should urgently address the evidential gap on the global burden of emergency presentations; 
doing so requires substantial global investment in cancer registration and the conduct of comparative 
studies.* 
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b. Understudied patient groups include paediatric and young adult cancer patients, and those with rarer 
cancers (18); international policy initiatives and research should aim to address these evidential gaps as a 
priority. * 
 
* Statements based on indirect evidence and consensus between the authors. 
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Box 1. Review Criteria 
 
Database Sources 
We searched PubMed, EMBASE, CINAHL, Web of Science, and the Cochrane Library from their inception, using 
the search terms “emergency or emergencies or urgent”, and “presentation or diagnosis or diagnose*”, and 
“neoplasm or cancer”. We restricted the search to human studies, without time (ie. From database inception) or 
language restrictions. An initial search was completed in February 2015, and updated in December 2015. Endnote 
was used to facilitate title and abstract inspection, and de-duplication. 
 
Eligibility Criteria 
We searched for population-based evidence about the frequency and predictors of diagnosis of cancer as an 
emergency. We included all empirical studies based on population-based evidence which examined “emergency 
diagnosis” or “emergency presentation” of cancer as an outcome or independent variable. We excluded case 
series arising from single hospital centres (because of concerns about generalisability), case reports, conference 
abstracts, commentaries and reviews. 
Box 2. Variation in frequency by tumour sub-site or sub-type 
 
In the few studies examining ‘colon’ and ‘rectal’ cancers separately, the average frequency of emergency 
diagnosis was approximately two-fold greater for colon cancer (e.g. 31% vs 15% for rectal cancer in Abel et al.) (6, 
11, 29, 37, 39)These findings may reflect differences in the nature of preceding symptoms or anatomical differences 
leading to variable risks of obstruction or perforation in either sub-site. Variation in the proportion of patients 
who are diagnosed as emergencies has also been reported for different colon sub-sites, although the evidence is 
inconsistent about whether the risk is greater for left- or right-sided tumours. (3, 6, 39). 
 
Similarly oesophageal and stomach cancers vary in emergency presentation frequencies, with average reported 
rates being 20% and 31% respectively (1, 5, 8, 37) These differences may reflect that a relatively high proportion of 
patients with oesophageal cancer present with a ‘red flag’ symptom (dysphagia). 
 
Within haematological cancers, higher frequency of emergency presentations are reported in non-Hodgkins 
compared to Hodgkin’s patients. (37) Similarly higher frequencies were reported for patients with acute 
compared to chronic leukaemias, with about half of all patients with acute leukaemia presenting as 
emergencies. (1, 37) 
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Box 3. Associations between stage and emergency presentation for different cancers 
 
Colorectal: odds ratio between 1.28 to 4.8, all p<0.05 for late vs early stages (3, 4, 6, 14, 40) 
Lung: odds ratio between 1.65 to 2.70, all p<0.05 for late vs early stages (4, 10, 14) 
Cervical: *odds ratio 14.7, 95% CI 11.1 – 19.6 for TNM stage 4 vs 1 at diagnosis (14) 
Breast: *odds ratio 13.9, 95%CI 3.2 – 59.7 for TNM stage 4 vs 1 at diagnosis (14) 
Prostate: *odds ratio 5.9, 95% CI 5.0 – 7.0 for TNM stage 4 vs 1 at diagnosis (14) 
Oesophago-gastric: 20 vs 13% of emergency cases for Stage IV vs I/II p<0.001 (8) 
 
10 cancers considered together: 30% of EP patients have stage 4 cancers at diagnosis, compared to 17% and 14% 
of those diagnosed through a 2-week-wait and non-2-week-wait referrals respectively; the proportion of 
emergency presenters with stage 4 cancer at diagnosis was 17% for bladder, 33% for breast, 32% for colorectal, 
30% for kidney, 59% for lung, 16% for melanoma, 21% for non-Hodgkin’s lymphoma, 29% for ovarian, 39% for 
prostate and 17% for uterine cancer. (21) 
 
___________ 
*Adjusted odds ratio for age, sex, co-morbidity (as measured by Charlson index), income deprivation; for TNM 
Stage 4 vs 1 
 
 
 
 
Box 4. Selected examples of associations between ethnicity and emergency presentation 
 
Type of cancer Country of Study Odds of Emergency Presentation 
Any of 15 
cancers 
England (1) OR 1.16 95% CI 1.08 – 1.24 
Asian vs White 
Colorectal England (2) OR 1.13 95% CI 1.02 – 1.24 
Non-white vs White 
Colorectal US (3) OR 1.28 95% CI 1.20 – 1.37  African-American vs 
White 
Colorectal US (4) OR 1.16 95% CI 0.97 – 1.38 African-American vs White 
Lung US (4) OR 1.42, 95% CI 1.42 – 1.66 
African-American vs White 
 
Box 5. The UK Routes to Diagnosis project – an exemplar for health record epidemiological studies to study 
emergency presentation. 
 
The great majority of epidemiological evidence on emergency diagnosis of cancer currently relates to the English 
“Routes to Diagnosis” project (Public Health England). Linking information from different sources such as cancer 
registration, hospital care and screening programme records, patients are assigned to different diagnostic 
‘routes’ (including emergency presentation but also screening detection and urgent or routine referral routes) 
using algorithms. The project provides for the largest population-based collection of data on the diagnostic route 
of incident cancer patients anywhere in the world, and can serve as a prototype for similar developments in 
healthcare systems benefiting from rich collections of electronic patient health records 
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Appendix 1: Descriptions of included studies / sources of evidence 
 
Study details Diagnosis period; data source Population (total cases) Number of 
emergency 
presenters (%) 
Cancer studied 
Abel et al, Br J 
Cancer 2015, 
UK (37) 
2006 – 2010; Routes to 
Diagnosis dataset* 
England (age 25+, 749 645) 232 281 (31) 27 non-gender-
specific cancers 
Barrett, Fam 
Pract 2006, UK 
(26) 
2002; 5 cases from each 
participating GP practice 
Exeter, Oxford and Sheffield 
(151) 
39 (26) Colorectal 
Barrett, BMC 
Fam Pract 
2008, UK (25) 
1998-2002; primary care 
records 
Exeter Primary Care Trust 
(246) 
71 Lung 
Barrett, Br J 
Obs & Gynae 
2010, UK (27) 
2000-2007; primary care 
records 
Exeter, East and Mid-Devon 
(women>40yr, 212) 
39 Ovarian 
Beckett, Lung 
Cancer 2014, 
UK (10) 
2006-2011; National Lung 
Cancer Audit in England 
England (133,530) 25 675 (19) Non-small cell lung 
cancer 
Bottle, Br J 
Cancer 2012, 
UK (1) 
2007 – 2010; Hospital 
Episodes Statistics 
England, (639064) 
 
*likely partially nested 
within Abel/Elliss-Brookes 
139 351 (22) 22 cancers 
 
Cleary, Fam 
Pract 2007, UK 
(28) 
1998-2002; primary care 
records 
Exeter PCT (349) 62 Colorectal 
Dejardin, Br J 
Cancer 2005, 
France (65) 
1995; Cancer registry data Nationwide (1413) 192 Colorectal 
Elliss-Brookes, 
Br J Cancer 
2012, UK (5) 
2006-2008; Routes to 
diagnosis dataset* 
England (739 667) 
 
*fully nested within Abel 
except for breast, prostate, 
cervix, endometrial, 
(24%) 15 cancers 
Gunnarsson, Eu 
J Surg Onc 
2013, Sweden 
(29) 
1997-2006; Cancer registry Uppsala-Orebro and 
Stockholm regions (12293) 
2856 (23) Colon 
Gunnarsson, 
World J Surg 
2014, Sweden 
(11) 
2006-2008; Cancer registry, 
review of primary and 
secondary care records` 
Regional Oncology Centre in 
Uppsala-Orebro (case 
control - 854) 
263 Colon 
 
McArdle, Br J 
Surg 2004, UK  
(6) 
1991-1994; Linked secondary 
care data with cancer registry. 
Scotland (3200) 986 Colorectal 
McPhail, Br J 
Cancer 2013, 
UK (14) 
2006-2008; Routes to 
diagnosis dataset* 
England (colorectal and 
cervical); East of England 
(prostate, breast, lung) 
(131,754) 
 
*fully nested within Elliss-
Brookes 
Percentages for 
individual 
cancers given 
5 cancers including 
cervical, colorectal, 
breast, lung and 
prostate 
Nouraei, 
Laryngoscope 
2014, UK (12) 
1996-2011; Hospital Episodes 
Statistics 
England (874) 353 (40%) primary tracheal 
Palser, BMJ 
Open 2013, UK 
(8) 
2007-2009; National 
Oesophago-gastric cancer 
audit 
England (14102) (16%) Oesophageal, 
Gastric 
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Pruitt, BMC 
Cancer 2014, 
USA (3) 
1992-2005; Linked SEER-
Medicare data 
Nationwide, aged 66+ 
(138,376) 
21313 (28%) Colorectal 
 
Rabeneck, Am J 
Gastroenterol 
2006, Canada 
(39) 
1996-2001; Linked Canadian 
Insitute for Health 
Information, Ontario Health 
Insurance Plan, Registered 
Persons Database 
Ontario (age 20+, 41356) 7739 (19%) Colorectal 
Raine, BMJ 
2010, UK (50) 
1999 – 2006; Hospital 
Episodes Statistics 
England (age 50+, 564821) 182 449 (32%) 
 
Colorectal 
Breast 
Lung 
Shawihdi, Gut 
2014, UK (45) 
2006-2008; Linked Hospital 
Episodes Statistics and Death 
registry 
England (22488) 
 
*likely partially nested 
within Abel/Elliss-Brookes 
(28%) Oesophagogastric 
Sheringham, Br 
J Cancer 2014, 
UK (40) 
2009-2011; Linked cancer 
registry, primary and 
secondary care records 
North East London (943) 
 
*likely partially nested 
within Abel/Elliss-Brookes 
228 (24%) Colorectal 
Sikka, Am J 
Emerg Med 
2012, USA (4) 
1996-2000; Linked cancer 
registry, Medicaid eligibility 
file and Census Summary File 
Michigan (age 65+, 20311) 4278 (21%) Colorectal 
Lung 
Tataru, Cancer 
Epidem 2015, 
UK (9) 
2006-2008; Linked Cancer 
registry, Hospital Episodes 
Statistics, National Lung 
Cancer Audit and Routes to 
Diagnosis dataset* 
England (93 783) 35042 (37%) Non-small cell lung 
cancer 
Tsang, BMC 
Health Serv Res 
2013, UK (44) 
1999-2008; Linked primary 
care records, Hospital 
Episodes Statistics and Office 
for National Statistics 
mortality data 
England (5870) 817 (13.9%) 22 cancers 
Wallace, Br J 
Cancer 2014, 
UK (2) 
2007-2011; Linked Hospital 
Episodes Statistics and 
National Bowel Cancer Audit 
England (82777) 17889 (21%) Colorectal 
Grey Literature 
NCIN Routes to 
Diagnosis 2006-
2013 (19, 24) 
2006-2013; Routes to 
diagnosis dataset 
England (2,152,704) (22%) 56 cancer sites 
NCIN Teenagers 
& Young Adults 
(18) 
2004-2008; Routes to 
Diagnosis 
England, 0-49 year olds 
(131353) 
0-14yr – (54%) 
15-49yr – (13%) 
10 cancer groups 
NCIN Major 
Resections (7) 
2006-2010; Linked cancer 
registry and Hospital Episodes 
Statistics 
England, excluding 0-14 year 
olds (971329) 
199466 (20.5) 20 cancer sites 
NCIN Cancer by 
Stage (21) 
2012-2013: Routes to 
Diagnosis 
England (574487) 118113 (20.6) 10 cancer sites 
Jones (2013) (20) 2010-2012: Retrospective 
audit of primary care records 
Thames Valley Cancer 
Network, 73 GP Practices 
(1579) 
142 (9%) 13 cancer groups 
and sites 
Newsom-Davies 
(2015) (22) 
2006-2008: Hospital case 
series 
European Thoracic Oncology 
members - 8 sites in Europe: 
(2315) 
534 (23.1) Lung 
* Routes to Diagnosis dataset consists of linked data from National Cancer Data Repository, Hospital Episodes Statistics, 
National Cancer Waiting Times, NHS screening programmes data in England 
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Appendix 2: Frequency of emergency presentation for different cancers 
 
Study Cancer Site Total number of cases 
(N) 
Number of EP 
(n) 
Proportion of 
EP (%) 
Colorectal 
Abel (2015) Colon 97880 30777 31 
Gunnarsson (2013) Colon 12293 2856 23 
Gunnarsson (2014) Colon 1430 158 11 
Abel (2015) Rectal 54076 8177 15 
Bottle (2012) Colorectal 80508 17285 22 
Cleary (2007) Colorectal 349 62 18 
Dejardin (2005) Colorectal 1413 192 14 
Elliss-Brookes (2012) Colorectal 91416 * 26 
McArdle (2004) Colorectal 3200 986 31 
Colon 2068 802 39 
Rectum 1091 170 16 
McPhail (2013) Colorectal 89484 * 26 
Pruitt (2014) Colorectal 
(emergency diagnosis) 
83330 * 29 
Colorectal 
(emergency surgery) 
55046 * 26 
Rabeneck (2006) Colorectal 41356 7739 19 
 Colon 21050 4572 22 
 Rectal 13216 1636 12 
 Other/Synchronous 7090 1531 22 
Raine (2010) Colorectal 186977 60684 33 
Sheringham (2014) Colorectal 943 * 24 
Sikka (2010) Colorectal 9030 * 23 
Wallace (2014) Colorectal 82777 17889 22 
     
Lung 
Abel (2015) Lung 162543 62498 39 
Barrett (2008) Lung 246 56 23 
Bottle (2012) Lung 62442 24803 40 
Elliss-Brookes (2012) Lung 96735 * 39 
McPhail (2013) Lung 9601 * 36 
Raine (2010) Lung 186741 96521 52 
Sikka (2010) Lung 11281 * 19 
Abel (2015) Mesothelioma 10116 3631 36 
Beckett (2014) NSCLC 133530 25675 19 
Tataru (2015) NSCLC 93783 35042 37 
     
Oesophago-gastric 
Abel (2015) Oesophageal 32470 7062 22 
Bottle (2012) Oesophageal 18946 3407 18 
Elliss-Brookes (2012) Oesophageal 19449 * 22 
Palser (2013) Oesophageal 9755 * 13 
Shawihdi (2014) Oesophago-gastric 22488 * 28 
Abel (2015) Stomach 29893 9913 33 
Bottle (2012) Stomach 13970 3684 26 
Elliss-Brookes (2012) Stomach 18613 * 33 
Palser (2013) Stomach 4347 * 24 
     
Gender-specific 
Barrett (2010) Ovarian 212 43 20 
Bottle (2010) Ovarian 12079 3493 29 
Elliss-Brookes (2012) Ovarian 16026 * 32 
Bottle (2010) Cervix 5964 779 13 
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McPhail (2013) Cervix 6950 * 12 
Bottle (2010) Prostate 55275 6487 12 
Elliss-Brookes (2012) Prostate 92922 * 10 
McPhail (2013) Prostate 11204 * 7 
Bottle (2010) Testis 4732 445 9 
Bottle (2010) Uterus 16017 1036 7 
Elliss-Brookes (2012) Uterus 18462 * 8 
Bottle (2010) Breast 101506 4170 4 
Elliss-Brookes (2012) Breast 110173 * 5 
McPhail (2013) Breast 12354 * 4 
Raine (2010) Breast 191103 25244 13 
     
Urogenital 
Abel (2015) Bladder 42234 7834 19 
Bottle (2012) Bladder 48333 3696 8 
Elliss-Brookes (2012) Bladder 25639 * 19 
Abel (2015) Renal 29469 7733 26 
Bottle (2012) Kidney 13653 3157 23 
Elliss-Brookes (2012) Kidney and unspecified 
urinary organs 
20594 * 25 
     
Other gastrointestinal 
Abel (2015) Pancreas 33295 16364 49 
Bottle (2012) Pancreas 13225 7436 56 
Elliss-Brookes (2012) Pancreas 19896 * 50 
Abel (2015) Small intestine 3399 1863 55 
Abel (2015) Liver 14732 7270 49 
Abel (2015) Anal 3381 345 10 
     
CNS 
Abel (2015) Brain 16710 11175 67 
Bottle (2012) Brain and CNS 13170 6484 49 
Elliss-Brookes (2012) CNS 11697 * 62 
     
Leukaemia 
Abel (2015) Hodgkin’s 4768 674 14 
Abel (2015) Non-Hodgkin’s 46329 12393 27 
Bottle (2012) Non-Hodgkin’s 23541 5318 23 
Elliss-Brookes (2012) Non-Hodgkin’s 25413 * 27 
Abel (2015) Multiple myeloma 18272 6693 37 
Bottle (2012) Multiple myeloma 9654 2674 28 
Elliss-Brookes (2012) Multiple myeloma 11221 * 37 
Abel (2015) CLL 11892 2950 25 
Abel (2015) CML 1702 656 39 
Bottle (2012) Chronic leukaemia 7192 1716 24 
Abel (2015) AML 9611 5388 56 
Bottle (2012) Acute leukaemia 8336 4087 49 
     
Oral-pharyngeal/ENT 
Abel (2015) Oral 9801 491 5 
Bottle (2012) Oral 9863 721 7 
Abel (2015) Oropharyngeal 6429 365 6 
Abel (2015) Laryngeal 8283 833 10 
Bottle (2012) Larynx 4764 661 14 
Abel (2015) Thyroid 8254 460 6 
Nouraei (2014) Tracheal 874 353 40 
     
Melanoma 
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Abel (2015) Melanoma 45561 967 2 
Bottle (2012) Melanoma 18933 414 2 
Elliss-Brookes (2012) Melanoma 26660 * 3 
     
Others 
Abel (2015) Soft-tissue sarcoma 4839 635 13 
Abel (2015) Unknown primary 43290 24805 57 
Bottle (2012) Other 96961 37398 39 
* Data not available in study, only percentage and total cases given 
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Appendix 3 Population based studies on EP and types of variables considered/mentioned by each 
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Abel (2015) (37)     Y Y  Y         Y   
Barrett (2006) (26)             Y       
Barrett (2008) (25)             Y       
Barrett (2010) (27)             Y       
Beckett (2014) (10)  Y   Y Y  Y Y Y         Y 
Bottle (2012) (1)     Y Y Y Y        Y Y   
Cleary (2007) (28)    Y                
Dejardin (2005) (65) EP = exposure variable 
Elliss-Brookes (2012) (5)    Y            Y  Y 
Gunnarsson (2013) (29)  Y   Y Y  Y         Y   
Gunnarsson (2014) (11)  Y  Y Y   Y Y    Y  Y    Y 
McArdle (2004) (6) Y Y  Y Y Y  Y          Y Y 
McPhail (2013) (14)  Y   Y Y  Y Y          Y 
Nouraei (2014) (12)                  Y Y 
Palser (2013) (8)  Y   Y Y  Y Y Y        Y Y 
Pruitt (2014) (3) Y Y Y  Y Y Y Y Y     Y Y  Y   
Rabeneck (2006) (39) Y Y   Y Y  Y Y    Y  Y  Y   
Raine (2010) (50)     Y Y  Y         Y Y  
Shawihdi (2014) (45)     Y Y   Y       Y    
Sheringham (2014) (40)  Y  Y Y   Y     Y Y      
Sikka (2010) (4)  Y   Y Y Y Y Y    Y Y      
Tataru (2015) (9)  Y   Y Y  Y Y Y       Y Y Y 
Tsang (2013) (44)     Y Y Y Y Y    Y Y  Y    
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Wallace (2014) (2)     Y Y Y Y Y        Y   
                    
GREY LITERATURE                    
NCIN 2006-2013 (2015) 
(19, 24) 
    Y Y Y Y         Y  Y 
NCIN Teenagers & 
Young Adults (2013) (18) 
    Y   Y         Y   
NCIN Major Resections 
(2015) (7) 
       Y          Y  
NCIN Cancer by Stage 
(2016) (21) 
  Y  Y Y Y Y            
Jones (2013) (20)         Y  Y  Y Y  Y    
Newsom-Davies (2015) 
(22) 
 Y Y Y Y   Y  Y        Y  
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